Dare Bioscience, Inc. financial data

Symbol
DARE on Nasdaq
Location
3655 Nobel Drive, Suite 260, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 68.9 % -22.9%
Debt-to-equity -341 % +45.9%
Return On Equity 250 % +35.8%
Return On Assets -104 % -199%
Operating Margin -1.24K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.5M shares +57.7%
Common Stock, Shares, Outstanding 9.03M shares +5.66%
Entity Public Float 34M USD -56.1%
Common Stock, Value, Issued 903 USD +5.74%
Weighted Average Number of Shares Outstanding, Basic 8.87M shares +5.47%
Weighted Average Number of Shares Outstanding, Diluted 8.87M shares +4.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.88M USD -95.8%
Revenue from Contract with Customer, Excluding Assessed Tax 25.4K USD +173%
Research and Development Expense 9.64M USD -48.6%
General and Administrative Expense 8.72M USD -20.5%
Operating Income (Loss) -18.5M USD +31.4%
Net Income (Loss) Attributable to Parent -18.6M USD -158%
Earnings Per Share, Basic -2 USD/shares -1.42%
Earnings Per Share, Diluted -2 USD/shares -0.47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.04M USD -69.3%
Other Assets, Current 152K USD -24.4%
Assets, Current 6.6M USD -68.3%
Property, Plant and Equipment, Net 1.65M USD +412%
Operating Lease, Right-of-Use Asset 956K USD -33.9%
Other Assets, Noncurrent 1.07M USD +102%
Assets 13M USD -45%
Accounts Payable, Current 1.76M USD -7.71%
Employee-related Liabilities, Current 806K USD +0.03%
Accrued Liabilities, Current 2.52M USD +101%
Contract with Customer, Liability, Current 205K USD
Liabilities, Current 19.2M USD +31.7%
Contract with Customer, Liability, Noncurrent 1M USD 0%
Operating Lease, Liability, Noncurrent 448K USD -56.8%
Liabilities 25.7M USD +22.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -403K USD -4.48%
Retained Earnings (Accumulated Deficit) -184M USD -11.3%
Stockholders' Equity Attributable to Parent -12.7M USD -577%
Liabilities and Equity 13M USD -45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.47M USD +19.7%
Net Cash Provided by (Used in) Financing Activities 247K USD +1657%
Net Cash Provided by (Used in) Investing Activities -157K USD -2056%
Common Stock, Shares Authorized 240M shares 0%
Common Stock, Shares, Issued 9.03M shares +5.66%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.37M USD +21.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.34M USD -68.1%
Deferred Tax Assets, Valuation Allowance 115M USD +2.13%
Deferred Tax Assets, Gross 115M USD +2.13%
Operating Lease, Liability 1.04M USD -32%
Depreciation 10.8K USD +13.4%
Payments to Acquire Property, Plant, and Equipment 157K USD +2056%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18.6M USD -159%
Lessee, Operating Lease, Liability, to be Paid 1.14M USD -35.4%
Property, Plant and Equipment, Gross 1.51M USD +88.6%
Operating Lease, Liability, Current 588K USD +20.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 130K USD -80.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 680K USD +3.03%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 104K USD -57%
Lessee, Operating Lease, Liability, to be Paid, Year Three 130K USD -75.4%
Deferred Tax Assets, Operating Loss Carryforwards 86.6M USD +0.47%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 2.82M USD +7.91%
Operating Lease, Payments 610K USD +20.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 158K USD +1367%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%